A cutting-edge mini-review published in the inaugural issue of Targetome elaborates on the value of proteome-wide ...
LET’S GET TECHNICAL. Scientists from the biotech company Life Biosciences are investigating the safety and potential side ...
Morning Overview on MSN
The first cellular age-reversal therapy has been cleared for human trials
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...
Today, more people are living past 100 than ever before — even though the maximum human lifespan hasn't moved past 115 years.
Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...
Plant regeneration represents a cornerstone of modern plant science, blending fundamental questions in developmental biology ...
Signal transduction and gene regulation are at the heart of cell and developmental biology, driving cell fate decisions and tissue homeostasis. In cancer, ...
With fresh focus on New Approach Methodologies (NAMs) to move away from animal models in biosciences and preclinical ...
The link between methylation age acceleration and incidence of brain glioblastoma: Two-sample bidirectional and multivariable Mendelian randomization analyses. This is an ASCO Meeting Abstract from ...
For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable vision loss. The risk: cancer.
Sparkling Sciences Co., Ltd., under TOMO YUME Group, announced it has obtained international INCI certification for iPSC Exosome and completed Kyoto University's patent licensing agreement. INCI Name: ...
11Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Sloan Kettering Institute for Cancer Research, New York, New York.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results